It was the year individual investors took over Wall Street. Again. In 2025, small-dollar day traders and other everyday investors played a bigger role in more markets than ever before. They traded ...

Markets shrugged off tariffs, a government shutdown and AI fears. The stock market surged to record highs in 2025, hurtling past tariffs, a government shutdown and fears of a bubble in artificial ...

The stock market has done better than expected in 2025. Can it repeat that feat in 2026? Going into this year a number of outlooks called for single-digit returns, citing high valuations and ...

November historically has been a strong month for the U.S. stock market. This year’s gains didn’t come easy. After finishing October in record territory, major U.S. equity indexes kicked off November ...

Crypto had a rough November. The pain is persisting into December — and that could signal trouble ahead for the stock market. Bitcoin has slumped more than 6% in the past 24 hours, sliding from just ...

For years, when it was time for startups to start selling their product, they could turn to any number of traditional playbooks. But as with so many things, AI is changing how companies prepare to go ...

During a reception and dinner event for business leaders in Japan several weeks ago, Donald Trump praised Treasury Secretary Scott Bessent for "soothing" the stock market whenever he "disturbs" it. "I ...

During his remarks at the APEC Summit in South Korea several weeks ago, Donald Trump revealed that he will manipulate the stock market whenever he announces "good news." Trump stated, "when we ...

Some of the year’s most popular emerging-market trades such as betting on the Brazilian real and stocks linked to artificial intelligence are becoming a source of concern as money managers warn of ...

A new market is coming to the heart of Atascadero, the latest addition in the city’s mission to revitalize its downtown center. Garden City Market — a family-owned, community-centered general store ...

Companies don’t generally cut prices out of generosity. For most of Big Pharma, drug discounts have largely been about damage control. After months of tariff threats and talk of tougher pricing rules ...